NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE426.25-5.45 (-1.26 %)
PREV CLOSE ( ) 431.70
OPEN PRICE ( ) 429.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 83360
TODAY'S LOW / HIGH ( )423.20 431.45
52 WK LOW / HIGH ( )279.65 470.9
NSE426.50-4.9 (-1.14 %)
PREV CLOSE( ) 431.40
OPEN PRICE ( ) 429.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 426.50 (145)
VOLUME 1487447
TODAY'S LOW / HIGH( ) 423.50 431.30
52 WK LOW / HIGH ( )278.85 471
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-09 2005
Management Info
Malempati Venugopala Rao - Chairman - Managing Director
Registered Office

Address Laurus Enclave, Plot Office 01,Edulapakabonangi Village, Parawada,Mandal, Anakapalli,
Vishakhapatnam,
Andhra Pradesh-531021

Phone 0891 3061222 / 6601222

Email info@lauruslabs.com

Website www.lauruslabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
19Apr USFDA completes inspection at Laurus L
United States Food & Drug Administration (USFDA) has completed inspe..
30Mar Laurus Labs informs about closure of t
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015,..
19Feb Laurus Labs invests over Rs 99 crore i
Laurus Labs has infused further equity into its wholly-owned subsidiary..
19Feb Laurus Labs soars on investing over Rs
Laurus Labs is currently trading at Rs. 409.05, up by 9.40 points or 2.3..
17Feb Laurus Labs informs about updates on a
With reference to disclosures dated May 31, 2023 and July 12, 2023 regar..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit426.47603.8
Gross Profit 567 10514.3
Operating Profit 181114977.1
Net Sales 11321.957734.5
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap (Rs. in Cr)846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap (Rs. in Cr)1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap (Rs. in Cr)55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap (Rs. in Cr)1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap (Rs. in Cr)16688.90
MORE
Shareholding Pattern
NON-INSTITUTION 35.07%
PROMOTERS 27.19%
MUTUAL FUNDS/UTI 6.68%
FI/BANKS/INSURANCE 4.75%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.